載入中
NYSEHealthcareMedical - Instruments & Supplies
最新資料
US$230.05
+US$3.32 · +1.46%
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
前收盤價
US$230.05
+US$3.32 · +1.46%
盤中時間採用ET。市場資料可能有所延遲。
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
日內區間
目前US$230.05
52週區間
目前US$230.05
盤中時間採用ET。市場資料可能有所延遲。
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
日內區間
目前US$230.05
52週區間
目前US$230.05
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 56.53億 USD | 51.46億 USD | 46.85億 USD | 42.23億 USD | 35.78億 USD |
| 銷貨成本 | 22.02億 USD | 20.91億 USD | 20.3億 USD | 18.67億 USD | 15.54億 USD |
| 毛利 | 34.52億 USD | 30.55億 USD | 26.55億 USD | 23.56億 USD | 20.24億 USD |
| 研究與開發 | 3.78億 USD | 3.31億 USD | 3.08億 USD | 2.88億 USD | 2.54億 USD |
| 銷售、一般及管理費用 | 11.2億 USD | 9.91億 USD | 9.17億 USD | 8.74億 USD | 7.39億 USD |
| 營業費用 | 15.43億 USD | 13.7億 USD | 13.35億 USD | 12.24億 USD | 10.24億 USD |
| 利息支出 | — | 1260.9萬 USD | 4570.8萬 USD | 4737.9萬 USD | 2231.2萬 USD |
| 折舊和攤銷 | 2.44億 USD | 2.36億 USD | 2.16億 USD | 1.98億 USD | 1.94億 USD |
| 營業利益 | 19.08億 USD | 16.85億 USD | 13.2億 USD | 11.32億 USD | 10億 USD |
| 淨利 | 15.23億 USD | 14.01億 USD | 10.21億 USD | 8.98億 USD | 7.79億 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$242.7
上漲空間 5.50%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2010年8月31日 | 2:1 | — | — |
股票分割 | 2005年10月3日 | 2:1 | — | — |
股票分割 | 2000年4月3日 | 2:1 | — | — |
股票分割 | 1998年11月17日 | 2:1 | — | — |
已生效 2010年8月31日
2:1
已生效 2005年10月3日
2:1
已生效 2000年4月3日
2:1
已生效 1998年11月17日
2:1
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T632.02億0.05%129.35兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI11.07億0.05%2.3兆 USD0.03%US$381.94+0.63%
Vanguard S&P 500 ETFVOO9.25億0.05%1.8兆 USD0.03%US$715.59+0.61%
Vanguard Morningstar Mid-Cap ETFVO7.53億0.33%2264億 USD0.03%US$81.14+0.92%
Vanguard Morningstar Growth ETFVUG4.44億0.12%3846億 USD0.03%US$91.97+0.72%
iShares Core S&P 500 ETFIVV4.35億0.05%8964.4億 USD0.03%US$781.97+0.60%
State Street SPDR S&P 500 ETFSPY3.99億0.05%8172億 USD0.09%US$778.57+0.60%
First Trust Rising Dividend Achievers ETFRDVY3.78億1.49%254.74億 USD0.47%US$79.58+0.19%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOVanguard Morningstar Growth ETFVUGiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYFirst Trust Rising Dividend Achievers ETFRDVYAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
